Phytopathology. 2003 Oct;93(10):1301-7. doi: 10.1094/PHYTO.2003.93.10.1301.
ABSTRACT We evaluated combinations of two strains of plant growth-promoting rhizobacteria (PGPR) formulated with the carrier chitosan for the ability to induce growth promotion of tomato plants and resistance to infection by Cucumber mosaic virus (CMV). Each PGPR combination included GB03 (Bacillus subtilis) and one of the following PGPR strains: SE34 (B. pumilus), IN937a (B. amyloliquefaciens), IN937b (B. subtilis), INR7 (B. pumilus), or T4 (B. pumilus). The PGPR combinations formulated with chitosan are referred to as biopreparations. Tomato plants treated with each of the biopreparations appeared phenotypically and developmentally similar to nonbacterized control plants that were 10 days older (referred to as the older control). When plants were challenged with CMV, all plants in the biopreparation treatments and the older control treatment had significantly greater height, fresh weight, and flower and fruit numbers than that of plants in the CMV-inoculated same age control treatment. CMV disease severity ratings were significantly lower for biopreparation-treated and older control tomato plants than for that of same age control plants at 14 and 28 days postinoculation (dpi). CMV accumulation in young noninoculated leaves was significantly less for all biopreparation-treated plants and those in the older control than for the same age control plants at 14 dpi and for four of the five biopreparation treatments at 28 dpi. In those tomato plants shown to be infected, the amount of CMV in noninoculated leaves was significantly lower for three of the biopreparation treatments and the older control treatment at 14 dpi and biopreparation G/INR7 treatment at 28 dpi when compared with the control treatment. These data show that treatment of tomato plants with biopreparations results in significant enhancement of growth and protection against infection by CMV.
摘要 我们评估了两种植物促生根际细菌(PGPR)菌株与载体壳聚糖组合的能力,以诱导番茄植株生长促进和对黄瓜花叶病毒(CMV)感染的抗性。每个 PGPR 组合都包含 GB03(枯草芽孢杆菌)和以下 PGPR 菌株之一:SE34(解淀粉芽孢杆菌)、IN937a(解淀粉芽孢杆菌)、IN937b(枯草芽孢杆菌)、INR7(解淀粉芽孢杆菌)或 T4(解淀粉芽孢杆菌)。用壳聚糖配制的 PGPR 组合称为生物制剂。用每种生物制剂处理的番茄植株在表型和发育上与 10 天大的非细菌对照植株相似(称为年长对照植株)。当植株受到 CMV 挑战时,生物制剂处理和年长对照处理的所有植株的高度、鲜重、花和果实数量都明显大于同龄对照植株。与同龄对照植株相比,生物制剂处理和年长对照植株的 CMV 病情严重程度评分在接种后 14 天和 28 天显著降低。在接种后 14 天和 28 天,与同龄对照植株相比,所有生物制剂处理和年长对照植株的年轻未接种叶片中 CMV 积累量显著减少。在接种后 14 天,与同龄对照植株相比,除了一种生物制剂处理外,所有生物制剂处理和年长对照植株的年轻未接种叶片中 CMV 积累量均显著减少,在接种后 28 天,五种生物制剂处理中有四种的 CMV 积累量显著减少。在显示感染的番茄植株中,与对照处理相比,三种生物制剂处理和年长对照处理在接种后 14 天和生物制剂 G/INR7 处理在接种后 28 天,非接种叶片中的 CMV 量显著减少。这些数据表明,用生物制剂处理番茄植株可显著促进生长,并防止感染 CMV。